Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on July 1, 2026

16 minutes ago

Human Appeal supports Syrian farmers through new wheat supply chain project

Indeterminate GlobeNewswire

40 minutes ago

60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue

Indeterminate GlobeNewswire

42 minutes ago

Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

Indeterminate GlobeNewswire

42 minutes ago

Stryker to announce second quarter 2026 financial results

Indeterminate GlobeNewswire

42 minutes ago

Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®

Indeterminate GlobeNewswire

42 minutes ago

NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026

Indeterminate GlobeNewswire

42 minutes ago

Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer

Indeterminate GlobeNewswire

42 minutes ago

Bay Hematology Oncology and American Oncology Network Welcome Dr. Bill Gai

Indeterminate GlobeNewswire

an hour ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches

Indeterminate GlobeNewswire

an hour ago

NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences

Indeterminate GlobeNewswire

an hour ago

FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT

Indeterminate GlobeNewswire

2 hours ago

Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director

Indeterminate GlobeNewswire

2 hours ago

Ocugen to Participate in Upcoming July Industry Conferences

Indeterminate GlobeNewswire

2 hours ago

Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences

Indeterminate GlobeNewswire

2 hours ago

iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study

Indeterminate GlobeNewswire

2 hours ago

INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion

Indeterminate GlobeNewswire

2 hours ago

Harrow Announces Commercial Launch of BYOOVIZ® in the United States

Indeterminate GlobeNewswire

2 hours ago

Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics

Indeterminate GlobeNewswire

2 hours ago

Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease

Indeterminate GlobeNewswire